Sorted By Test Name - Mayo Medical Laboratories

EPOR
61679
FESC
91458
FFES
no erythropoietic response to EPO therapy, but high-normal or high EPO levels, may have additional,
unrecognized cause(s) for their anemia. If no contributing factors can be identified after adequate further
study, the possibility that the patient may have developed EPO-antibodies should be considered. This can
be a serious clinical situation that can result in red cell aplasia, and should prompt expeditious referral to
hematologists or immunologists skilled in diagnosing and treating this disorder.
Reference Values:
2.6-18.5 mIU/mL
Clinical References: 1. Tefferi A: Diagnosing polycythemia vera: a paradigm shift. Mayo Clin Proc
1999;74:159-162 2. Hoagland HC: Myelodysplastic (preleukemia) syndromes: the bone marrow factory
failure problem. Mayo Clin Proc 1995;70:673-677 3. Casadeval N: Pure red cell aplasia and
anti-erythropoietin antibodies in patients treated with epoetin. Nephrol Dial Transplant 2003;18 (Suppl.
8):viii37-viii41 4. Fisher JW: Minireview: Erythropoietin: Physiology and Pharmacology Update. Exp
Biol Med 2003;228:1-14 5. Strippoli GFM, Manno C, Schena FP, Craig JC: Haemoglobin and
haematocrit targets for the anaemia of chronic kidney disease. The Cochrane Library, 2005, Volume 2
Erythropoietin Receptor (EPOR) Gene, Exon 8 Sequencing
Clinical Information: Only orderable as part of a profile. For further information see HEMP/61337
Hereditary Erythrocytosis Mutations.
Useful For: Only orderable as part of a profile. For further information see HEMP/61337 Hereditary
Erythrocytosis Mutations.
Interpretation: Only orderable as part of a profile. For further information see HEMP/61337
Hereditary Erythrocytosis Mutations.
Reference Values:
Only orderable as part of a profile. For further information see HEMP/61337 Hereditary Erythrocytosis
Mutations.
Clinical References:
Escitalopram, Serum/Plasma
Reference Values:
Reporting limit determined each analysis
Synonym(s): Celexa/Lexapro
Steady-state peak plasma levels from patients on regimen of
10 or 30 mg/day of Escitalopram:
21 and 64 ng/mL, respectively, and occur at approximately
4 hours post dose.
This test is not Chiral specific. Patients who have taken Racemic
Citalopram (Celexa), as opposed to Escitalopram (Lexapro), within
the past 3 days may have falsely elevated values.
Test Performed By: NMS Labs
3701 Welsh Road
Willow Grove, PA 19090-0437
Estradiol Free, Serum (includes Estradiol and SHBG)
91215
Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 684